Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum GB Group Ord Shs GBGPF

GB Group plc is a United Kingdom-based company, which provides identity data intelligence products and services helping organizations recognize and verify all elements of an individual's identity at key interactions in their business processes. The Company's segments include location, identity and fraud. The location segment includes address lookup, verification and capture; e-mail validation... see more

OTCPK:GBGPF - Post Discussion

GB Group Ord Shs > News out......
View:
Post by thorgb1 on Jan 15, 2018 7:36am

News out......

A Second Leading Independent Proxy Advisor, Glass Lewis, Recommends CanniMed Shareholders Vote “FOR” the Newstrike Acquisition

Shareholders will recognize real synergies for real value through the combination of these two great companies

CanniMed Therapeutics Inc. (TSX:CMED) (“CanniMed” or the “Company”) is pleased to announce that Glass Lewis & Co (“Glass Lewis”), a second leading independent proxy voting advisory firm, has recommended that CanniMed shareholders vote “FOR” the acquisition of Newstrike Resources.

Glass Lewis' recommendation follows Institutional Shareholder Services’ ("ISS") last week in recommending CanniMed shareholders vote FOR on managements Green Proxy.

In reaching its recommendation that CanniMed shareholders vote “FOR,” Glass Lewis stated:

“Our analyses suggest that the Newstrike/CanniMed merger represents the superior value proposition for CanniMed shareholders at this time” while also recognizing that the “recent run-up in Newstrike’s share price, together with the merger exchange ratio, would seemingly imply a significant amount of upside for CanniMed’s shares.”

In addressing the hostile bid from Aurora, Glass Lewis confirms that “the Aurora Offer represents a largely opportunistic attempt by Aurora to gain control of the Company on terms that largely favor Aurora at the detriment to CanniMed shareholders, particularly in an industry upside scenario.

“The Aurora Offer, as currently structured, effectively restrains the near-term upside to CanniMed, particularly as the share prices of Aurora and most other cannabis firms have risen since Aurora first announced its offer…considering the foregoing, the headline unaffected market premium of the Aurora Offer is no longer financially compelling to CanniMed shareholders, in our view.”

Glass Lewis also added “Had Aurora been truly serious about acquiring the Company for a fair value, we believe that Aurora would have proposed a structure that did not cap the value being offered to CanniMed shareholders.”

Brent Zettl President and CEO, CanniMed, stated in response to the positive recommendation: “We welcome the positive recommendation from Glass Lewis as momentum continues to build in our favour against the opportunistic bid from Aurora and in support of the accretive Newstrike acquisition. Glass Lewis clearly understands that the hostile bid makes no sense whatsoever for our shareholders. We encourage our shareholders to follow the recommendation of Glass Lewis, ISS and the Board, by voting FOR the acquisition of Newstrike and saying NO to Aurora by not tendering and not voting on the blue proxy.”

Shareholders are reminded every vote counts regardless of how many shares they own and to vote their green proxies by January 19th, 2018 at 10:00 a.m. (Toronto time).

If you need help voting, please contact Kingsdale Advisors at 1-888-518-1554 toll-free in North America, or 416-867-2272 outside North America or by email at contactus@kingsdaleadvisors.com. We have a team standing by to help make it easy to vote your proxy or voting instruction form.


Read more at https://www.stockhouse.com/news/press-releases/2018/01/15/a-second-leading-independent-proxy-advisor-glass-lewis-recommends-cannimed#skO7iBlEMXk2wBwv.99
Comment by JuicemanJames on Jan 15, 2018 8:02am
Hahaha yeah if I was Brett, I would've done the same thing by having Glass Lewis release a "recommendation" to shareholders!  Newstrike is a terrible company and a bizarre deal for CMED. On on a side note: No disrespect to the band but the tragically Hip lost their singer to cancer last year and won't be putting out any new music or playing concerts anymore... How exactly ...more  
Comment by Soccerguy on Jan 15, 2018 8:02am
who the heck is glass lewis....sounds sketch
Comment by lashout on Jan 15, 2018 8:14am
This post has been removed in accordance with Community Policy
Comment by Wildville on Jan 15, 2018 8:47am
Just my opinion from an outside looking in. Things don't look good for cmed. But by the looks of things. If it wasn't for auroras price at 24$ . We probably see cmed back in the teens. All the other mj stock are roll right back.
Comment by thorgb1 on Jan 15, 2018 9:01am
LOL, morons out in full force this morning. Whole sector is going to be bloody today, retailers going to panic and make everything worse. ACB looking like it might open near 8 bucks. With their share price tanking, if they want to get this deal done, it would be good for everyone if they just came back and offered 4.5 shares uncapped and got this over with. 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities